ANI Pharmaceuticals Inc (ANIP) — Capital Reinvestment Ratio
ANI Pharmaceuticals Inc (ANIP) has a Capital Reinvestment Ratio of 0.79x as of December 2025, meaning it reinvests 1% of its operating cash flow ($30.37 Million) in capital expenditures ($23.86 Million). Check ANI Pharmaceuticals Inc (ANIP) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ANI Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks ANI Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see ANI Pharmaceuticals Inc cash flow conversion.
Annual Capital Reinvestment Ratio for ANI Pharmaceuticals Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for ANI Pharmaceuticals Inc from 2007 to 2025. See ANIP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | $185.22 Million | $13.84 Million | ▼ -71.8% |
| 2024 | 0.26x | $64.02 Million | $16.95 Million | ▲ +70.2% |
| 2023 | 0.16x | $118.96 Million | $18.51 Million | ▼ -97.8% |
| 2021 | 7.12x | $3.32 Million | $23.64 Million | ▲ +59.0% |
| 2020 | 4.48x | $15.27 Million | $68.32 Million | ▲ +641.2% |
| 2019 | 0.60x | $45.63 Million | $27.55 Million | ▲ +271.1% |
| 2018 | 0.16x | $67.07 Million | $10.91 Million | ▼ -94.1% |
| 2017 | 2.74x | $39.42 Million | $107.99 Million | ▼ -49.5% |
| 2016 | 5.43x | $27.47 Million | $149.06 Million | ▲ +186.6% |
| 2015 | 1.89x | $17.26 Million | $32.68 Million | ▲ +16.7% |
| 2014 | 1.62x | $22.03 Million | $35.75 Million | ▲ +3980.5% |
| 2007 | 0.04x | $739.99K | $29.43K | — |